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Abstract
The main adaptive immune response to bacteria is mediated by B cells and CD4+ T-cells. However, some bacterial proteins
reach the cytosol of host cells and are exposed to the host CD8+ T-cells response. Both gram-negative and gram-positive
bacteria can translocate proteins to the cytosol through type III and IV secretion and ESX-1 systems, respectively. The
translocated proteins are often essential for the bacterium survival. Once injected, these proteins can be degraded and
presented on MHC-I molecules to CD8+ T-cells. The CD8+ T-cells, in turn, can induce cell death and destroy the bacteria’s
habitat. In viruses, escape mutations arise to avoid this detection. The accumulation of escape mutations in bacteria has
never been systematically studied. We show for the first time that such mutations are systematically present in most
bacteria tested. We combine multiple bioinformatic algorithms to compute CD8+ T-cell epitope libraries of bacteria with
secretion systems that translocate proteins to the host cytosol. In all bacteria tested, proteins not translocated to the cytosol
show no escape mutations in their CD8+ T-cell epitopes. However, proteins translocated to the cytosol show clear escape
mutations and have low epitope densities for most tested HLA alleles. The low epitope densities suggest that bacteria, like
viruses, are evolutionarily selected to ensure their survival in the presence of CD8+ T-cells. In contrast with most other
translocated proteins examined, Pseudomonas aeruginosa’s ExoU, which ultimately induces host cell death, was found to
have high epitope density. This finding suggests a novel mechanism for the manipulation of CD8+ T-cells by pathogens. The
ExoU effector may have evolved to maintain high epitope density enabling it to efficiently induce CD8+ T-cell mediated cell
death. These results were tested using multiple epitope prediction algorithms, and were found to be consistent for most
proteins tested.
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Introduction
CD8+ T-cells recognize mainly cytosolic epitopes presented on
MHC-I molecules. Their response is thus assumed to be directed
mainly against viruses [1,2,3]. Bacterial proteins, on the other
hand, are typically expressed outside the cytosol, and as such,
induce CD4+ T-cells and B cells responses [4,5,6,7,8,9,10], and
are not expected to induce a CTL response in the classical
pathway. For such a response to occur, these proteins must reach
MHC-I proteins in the ER.
One extensively studied possible mechanism for the presentation
of bacterial epitope is "cross presentation". In general, "cross
presentation" refers to the transfer of peptides from the MHC-II
presentation pathway to the MHC-I presentation pathway and vice
versa [11,12,13,14]. Specifically, peptides of intracellular bacterial
proteins derived from endosomal cleavage are presented on MHC-I
molecules. Thiscould take place in two ways: either the peptides are
translocated to the cytosol, cleaved by the proteasome and delivered
to the ER through TAP where they bind to MHC class I molecules,
or endosomal peptides bind to MHC-I molecules probably in the
endocytic compartment itself (for a review see [15]).
Another much more direct mechanism is the translocation of
bacterial protein to the cytosol by highly conserved secretion
systems. Such systems exist in a variety of bacteria. The secretion
system that has been most characterized is the type III secretion
system (T3SS) in gram-negative bacteria. The T3SS is a complex
that allows bacteria to deliver protein effectors across eukaryotic
cellular membranes through needle-like structure. In the cytosol,
T3SS effectors exert many effects, such as cellular invasion [16],
modulation of host immune response [17,18] and apoptosis [19].
Another secretion system is the ESX-1 system in Mycobacterium
tuberculosis (TB) [20]. Similar systems (also called ESX/T7S systems)
exist in other gram positive bacteria as well [21]. However, since
these systems do not have a needle-like structure, they cannot inject
proteins through the plasma membrane. Nevertheless, TB is an
intracellular bacterium and its secreted proteins can gain access to
the cytosol [22]. The third characterized system that injects
cytosolic proteins was studied in the intracellular cytosolic
bacterium Listreria monocytogenes that injects the virulence factors
Listeriolysin O (LLO) and ActA to the host cytosol [23].
These proteins are good candidates for presentation on
MHC class I molecules. In similar situations, viruses avoid the
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[1,24,25,26,27,28]. Here we study bacterial sequences to test
whether bacteria adopt a similar strategy of epitope removal.
Specifically, we systematically compute the epitope density in
bacterial effector proteins and show a clear selection against the
presentation of epitopes. This selection is highly specific to
cytosolic proteins.
Evidences for MHC-I presentation in bacteria are limited to
specific bacterial proteins, such as the L. monocytogenes proteins
listeriolysin O [29] and ActA [30], the Bordetella pertussis
adenylatecyclase toxin [31], the TB CFP10 antigen [22] and
Streptococci protein streptolysin O [32]. A CTL response to
extracellular pathogens was also suggested by some studies.
Bergman et al. showed that the CTL response has a critical role
in eliminating Yersinia infections, and that this response is directed
against Yops, the secreted effector proteins of Yersinia [33]. Other
studies about the CTL response against extracellular pathogen
were carried out by Meissner et al. that demonstrated a vigorous
CD8+ T cell influx into the lung in response to Pneumocystis,a n
extracellular fungal pathogen [34], and by Mehrzad et al. (2008)
that showed that trafficking of CD8+ T cells during initiation of
Escherichia coli mastitis is accelerated when increasing the E. coli
inoculum dose [35]. However, none of these studies suggested the
existence of escape mutations in bacteria. We here show that such
escape mutations are common in most tested effector proteins.
The field of immunomics has made a significant leap forward in
the last decades. Tools for epitope prediction have been developed
for most branches of the immune system. The precision of CD8+ T
cell epitopes prediction processing and presentation tools has
reached the level that allows a systematic prediction of full organism
epitope libraries. CTL epitopes are typically 8-10 amino acid long
peptides, bound to MHC-I molecules [36]. These peptides are
presented after proteasomal cleavage and transfer from the cytosol
via TAP to the ER [37,38], where they bind to MHC-I molecules.
We have developed a precise cleavage prediction algorithm [39]
and used TAP [40] and MHC binding [41] algorithms, which were
found to be precise enough for most MHC-I alleles, to compute
presentedepitopesdensities[24,25,42,43,44].Theprecisionofthese
densities has been tested in depth [24,43,44].
In this study, we study the epitope density of proteins in a group
of representative bacteria expressing proteins translocated to the
cytosol. Three of them, Escherichia coli, Shigella flexneri, and
Pseudomonas aureginosa, are gram-negative T3SS-containing bacte-
ria. In parallel, we study cytosol-exposed proteins from the gram-
positive Listeria monocytogenes and Mycobacterium tuberculosis. In order
to validate the results, we repeat the analysis using three different
algorithms to test that the results obtained are not the artifact of
the specific MHC binding algorithms used.
Results
SIR score
We have previously conducted a systematic analysis of the
predicted CTL epitope repertoire in human and foreign proteins,
and defined the normalized epitope density of a protein or an
organism as the Size of Immune Repertoire (SIR) score
[24,25,39,43,45,46,47]. The number of predicted CTL epitopes
from a sequence was computed by applying a sliding window of
nine amino acids, and computing for each nine-mer and its two
flanking residues whether it is cleaved by the proteasome and
whether it binds to TAP channels and to a given MHC-I allele
(Figure 1). The SIR score was defined as the ratio between the
computed CTL epitope density (fraction of nine-mers that were
predicted to be epitopes) and the epitope density expected within
the same number of random nine-mers. The choice of the
‘‘random’’ nine-mers will be discussed in the following section. An
average SIR score of less than 1 represents an under-presentation
of epitopes, whereas an average SIR score of more than 1
represents an over-presentation of epitopes. For example, assume
a hypothetical sequence of 1,008 amino acids (1,000 nine-mers)
containing 15 HLA A*0201 predicted epitopes. If the average
epitope density of HLA A*0201 in a large number of random
proteins was 0.01 (i.e. 10 epitopes in 1,000 nine-mers), then the
SIR score of the sequence for HLA A*0201 would be 1.5 (15/10).
The average SIR score of a protein was defined as the average of
the SIR scores for each HLA allele studied, weighted by the allele’s
frequency in the average human population. These results
obviously depend on the definition of a ‘‘random protein’’. We
have thus tested multiple such definitions.
Defining the baseline for the SIR score
An important issue in the analysis of selection is the baseline
against which the number of epitopes of a given protein is
compared. In previous work on viruses [24,25,43,48], we have
compared human to parallel non-human viruses as a negative
control. However, bacteria have a wide range of possible hosts and
purely non-human homolog bacteria often do not exist. We thus
use three different background distributions to compare with:
N In order to produce the first baseline, we have produced a long
random sequence of amino acids that have the typical amino
acid sequence composition of viral proteins. We have then
computed the epitope density in this sequence for each allele,
and defined it as the average expected epitope density for this
allele. This value is used as the denominator of the SIR score
for each allele. The advantage of this baseline is that it is
uniform over all proteins.
N A second, baseline, which is protein dependent, is the average
epitope density over 50 sequences produced by permuting the
order of the amino acids in the protein (scrambled versions of
the protein). Although these scrambled versions have no
biological viability, they gives a picture of the typical epitope
density of proteins with similar amino acid distribution in
Author Summary
Bacterial proteins are mainly exposed to B-cells and CD4+
T-cells, while CD8+ T-cells (CTL) typically respond to
viruses. The limitation of the CTL response to viruses
results from processing pathways of epitopes presented to
CTLs. These epitopes usually stem from proteins expressed
in the cytosol. Such proteins are eventually degraded and
presented on MHC-I molecules to CTLs. However bacterial
Type III secretion system (T3SS) effectors also have an
access to the host cytosol and may also be exposed to CTL
response. Thus, we can assume that this group of proteins
undergoes selection against the presentation of CTL
epitopes, as seen in viral proteins. Using multiple epitope
prediction algorithms, we show that most T3SS effectors,
as well as LLO, and ActA in Listeria monocytogenes and
ESAT-6 proteins in Mycobacterium tuberculosis, are system-
atically selected to reduce the number and quality of their
epitopes. The exception in this respect is the Pseudomonas
aeruginosa effector ExoU that has high density of high
quality epitopes. Since ExoU is known to induce rapid cell
death in hosts cells, we assume that P.aeruginosa utilize
the immune response to induce such death. The E.coli
epitope density is highly variable among strains.
CTL Response Against Cytosolic Bacterial Proteins
PLoS Computational Biology | www.ploscompbiol.org 2 October 2011 | Volume 7 | Issue 10 | e1002220which selection does not play a role. Such a baseline can, for
example, neutralize the effect of hydrophobicity on the epitope
density [48,49,50,51].
N The third baseline is the epitope density in a randomly selected
group of proteins in the same bacteria. Such a baseline
represents the difference between protein groups (the random
group and the group of interest) in the same bacteria.
In the following section, we will use all three baselines to show
that selection occurs in cytosolic bacterial proteins.
Typical bacterial proteins show no specific escape
mutations
While most viral proteins are expressed in the cytosol and
exposed to the MHC-I presentation pathway, bacterial proteins
are usually expressed either within the bacteria or within the
endosome of a phagocyte, and hence are not exposed to the
MHC-I presentation pathway. Thus, we expected that in contrast
with viruses [24,25,42,43,44], the SIR score of all bacterial proteins
would be distributed around 1.
The epitope density of a protein is affected by two main
elements: A) a direct negative selection of epitopes through the
immune response against pathogens expressing proteins carrying
many epitopes, B) inherent features of the protein, determining its
amino acid usage, which in turn affects the epitope density. In
order to check for the direct effect of negative selection, we
compared the SIR score of each protein, not only to 1, but also to
the SIR score of scrambled sequences with identical amino acid
distribution (that we denote as the neutral SIR score). When all
bacterial proteins are analyzed, the SIR scores distributions of the
real and scrambled proteins are similar and are close to 1 (Figure 2,
T-test , P-value.0.15 for all bacteria tested).
Bacterial proteins translocated to the cytosol are selected
to evade CTL recognition
While most bacterial proteins have the expected epitope density
(Figure 2), the epitope density of bacterial proteins that are
secreted to the host cytosol may be affected by CTL mediated
selection. Such proteins are often present at high concentrations in
the cytosol and are exposed to the MHC-I presentation pathway.
Five examples of such bacteria are tested in this study: P.
aeruginosa, S.flexneri, E.coli, L.monocytogenes and M.tuberculosis. Before
examining each bacterium separately, we compared the SIR score
in all cytosolic proteins of these bacteria against the SIR score in
randomly selected proteins, against scrambled versions of
themselves and against 1. In all three cases, the SIR score of the
cytosolic bacterial proteins were significantly lower (ANOVA P-
value,1.e-11 for all three tests). No significant differences were
found between the SIR score of randomly selected proteins and
their scrambled versions. (ANOVA P-value=0.9114). These
results suggest that bacterial proteins located in the host cytosol
have evolved to evade CTL recognition.
The most characterized bacterial cytosolic proteins are the
effector proteins of secretion systems in gram negative bacteria.
We analyzed the SIR score of bacterial proteins in bacteria where
we had a clear definition of effector proteins. We first analyzed P.
aeruginosa , S. flexneri and E.coli as models for gram negative bacteria
with Type III secretion systems. S. flexneri represents intracellular
bacteria, P. aeruginosa represents cytopathic extracellular bacteria
and E. coli (entropathogenic (EPEC) and enterohemoreagic
(EHEC) subgroups) represent extracellular non-cytopathic bacte-
ria. In the following sections, we show that systematically, in most
bacteria tested, the epitope density in effector proteins is lower
than expected, with one interesting exception.
Pseudomonas aeruginosa effectors. P. aeruginosa is a major
cause of health care associated infections. It has only four known
effector proteins: ExoS, ExoT, ExoU and ExoY. Almost all
Pseudomonas strains contain ExoY and ExoT (89% and 96%,
respectively) [52]. However, nearly all strains have either the ExoS
or the ExoU gene but not both [53]. ExoS has several adverse
effects on the host cell, including actin cytoskeleton disruption
(associated with cell rounding) and inhibition of DNA synthesis,
vesicular trafficking, endocytosis and cell death. ExoS induced
stress is characterized by slow death induction of the infected cell.
ExoU is a potent phospholipase that is capable of causing rapid
cell death in eukaryotic cells. ExoU containing strains of P.
aeruginosa are much more cytopathic than their ExoS containing
counterparts, which are more invasive.
In Pseudomonas aeruginosa - all effectors proteins have
low epitope densities, except for the ones inducing cell
death. As shown in Figure 3A, in all P. aeruginosa effectors
besides ExoU, the SIR score was significantly lower than 1 (T-test
P-value,1.e-4), lower than the neutral SIR score (the SIR score of
scrambled versions of the same proteins) (ANOVA P-
Figure 1. Algorithm for epitope prediction and SIR score
computation. Each protein is divided into all nine-mers and the
appropriate flanking positions (a). For each eleven-mer (a nine-mer and
the C and N flanking positions), a cleavage score is computed (b). We
compute for all peptides with a positive cleavage score a TAP binding
score and choose only supra-threshold peptides (c). The MHC binding
score of all TAP binding and cleaved nine-mers is computed (d). Nine-
mers passing all these stages are defined as epitopes. We then compute
the number of epitopes per protein per HLA allele (e). The ratio
between the number of predicted epitopes and the parallel number on
a random sequence with a random amino acid distribution is defined as
the SIR score.
doi:10.1371/journal.pcbi.1002220.g001
CTL Response Against Cytosolic Bacterial Proteins
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non-effector proteins (ANOVA P-value=2.4e-6). All randomly
selected -non-effector- proteins showed no difference between the
actual and the neutral SIR score. These results suggest that P.
aeruginosa effectors, ExoS, ExoY and ExoT, are selected to present
less CTL-epitopes. The special case of the fourth effector, ExoU
will be discussed later. SIR scores for each effector separately are
given in Supplementary Material, table S2.
Shigella flexneri effectors. Shigella species are gram-negative
bacteria that can colonize the intestinal epithelium by exploiting
epithelial-cell functions [54]. The first step of the Shigella infection
is crossing the intestinal epithelial barrier. When this is achieved,
the bacterium enters the macrophages that reside within the
microfold-cell (M-cell) pocket. S.flexneri effectors can be divided
into early and late subsets. The early effectors, IpaA, IpaB, IpaC,
IpgB1, IpgB2, IpgD and VirA, are secreted early in the infection,
immediately after contact with the epithelial cell. Their function is
mainly to promote bacterial basolateral entry into polarized
epithelial cells.
When Shigella reaches the epithelium, it secretes the late effectors
subset: IcsB, VirA, OspF, OspG and IpaH family proteins (VirA is
secreted in both stages). These effectors facilitate bacteria
intracellular survival, promote intra and intercellular movement,
and modulate the host inflammatory response [55].
In Shigella flexneri, all effectors have a low epitope
density, but early expression effectors have the lowest
epitope density. We have previously shown in viruses that
early expressed proteins are under a more stringent pressure than
late ones [24,25,43]. We have tested whether the same
phenomenon occurs in bacteria. In Figure 3B, the SIR score of
early and late effectors as well as non-effectors proteins is
compared to their scrambled versions. Again, in non-effectors
proteins, the neutral SIR score is very similar to the actual SIR
score. In effectors, the SIR score is significantly lower than both 1
(T-test P-value,1.e-15) and than other bacterial proteins in the
Shigella (ANOVA P-value=4.8e-4). The decrease against the
neutral score is not significant (ANOVA P-value=0.294).
However, when using other prediction algorithm, this decrease
is also significant, as shall be further discussed.
The decrease in the epitope number was much more significant
in early effectors than in late effectors (ANOVA P-value 1.0e-10).
Early effectors have a significantly lower SIR score than 1 (T-Test
P-value=6.4e-19), other proteins (ANOVA P-value=3.16e-13),
or their own Neutral SIR score (ANOVA P-value 8.8e-4). In late
effectors, the decrease was not significant (P-values=0.69, 0.12
and 0.71 is the three tests above), as was observed in viruses
[24,25,43].
Therefore, beyond the general CTL-induced selection ob-
served in effectors, these results suggest a differential force of
selection in S. flexneri effectors proteins, where early effectors are
under stronger pressure to hide their CD8+ Tc e l le p i t o p e st h a n
late ones.
Figure 2. Upper row and lower left drawings - Histograms of SIR score values for real and scrambled sequences of bacterial
proteins. The x axis is the SIR scores and the y axis is the frequency of sequence with such an SIR score. Each drawing represents a different
bacterium. The dark lines are the real sequences and the gray lines are the values obtained for scrambled versions of the same sequences. The
distributions of the real and scrambled sequences overlap showing that bacteria, unlike viruses, do not generally accumulate escape mutations in
their CTL-epitopes (P=0.4306,0.1574 and 0.1942 for Shigella, E.coli and Pseudomonas, respectively). The lower left drawing is the SIR score histogram
in human viruses (dark line) and the parallel in non human viruses (gray line). The average human virus SIR score is lower than the one of non-human
viruses, revealing the accumulation of escape mutations in human viral proteins (P value,1.e-7).
doi:10.1371/journal.pcbi.1002220.g002
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PLoS Computational Biology | www.ploscompbiol.org 4 October 2011 | Volume 7 | Issue 10 | e1002220Escherichia coli effectors. Escherichia coli are gram negative
bacteria whose main natural habitat is the gastrointestinal tract of
warm-blooded organisms (for review see [56]). Most strains exist as
harmless symbionts, but some are pathogenic. Two of them,
EPEC (enteropathogenic E. coli) and EHEC (Enterohemorrhagic
E. coli), consist of a 35-kb genetic element known as the ’locus of
enterocyte effacement’ (LEE) [57]. This locus encodes for 41
different genes, at least 5 of which are T3SS-effectors proteins (Tir,
Map, EspF, EspH, and EspZ). Many functions have been
suggested for these effectors, including re-organizing the actin
filopodia and pedestals (Tir, Map and EspH [58,59,60]), altering
septin cytoskeleton (EspF [61]), and inhibiting apoptosis (EspZ
[62]). All these effectors are located and act in the host-cell cytosol.
Moreover, their secretion is vital for the initiation of the E. coli
infection of enterocytes, and are thus expressed at the early stages
of the infection [63].
Escherichia coli- selection for CD8+ T cell evasion in
T3SS-effector. Figure 3C represents the comparison between
the SIR score of these effectors proteins and the score of all non-
effectors E. coli proteins. As expected, for most of E.coli strains
tested, T3SS effectors have lower epitope densities than 1 (T test P-
value,1.e-3), than other proteins from the same bacterium (ANOVA
Figure 3. SIR score of T3SS effectors and non-effectors proteins in Shigella flexneri, Pseudomonas aeruginosa and Escherichia coli.
A) Comparison between the average SIR score in real sequences and in scrambled sequences in Pseudomonas aureginosa. The first column is the
average over 400 randomly selected proteins and the second column is the average of ExoT, ExoS and ExoY (non-necrotic effectors). The third column
is the average of the necrotic effector ExoU. The first column has a similar average for the real and scrambled sequences (P value.0.18). In the second
column, the real T3SS effectors sequences have a lower averaged SIR score than randomly selected proteins and also than expected from their
scrambled sequences (P values=2.4e-6 and 0.011, respectively). The third column demonstrates that ExoU has a higher SIR score than randomly
selected proteins and than expected from its scrambled sequences (P-value,1e-4). B) Comparison between the average SIR score in real sequences
and in scrambled sequences in Shigella flexneri. The first column is the average over 400 randomly selected proteins. The second column is the
average over all T3SS effectors. The third and fourth columns are the averages over all early secreted and late secreted effectors, respectively. The first
column has a similar average for the real and scrambled sequences (P value.0.3). Again, as in P. aureginosa, effectors have a lower SIR score average
than randomly selected proteins, and also than expected from their scrambled sequences (second, third and fourth columns). Moreover, this bias is
much stronger in early secreted effectors (*P-value,8e-4.). The differences in the second and fourth columns (overall and late effectors) are not
significant (P-value.0.2). C) Comparison between the average SIR score in real sequences and in scrambled sequences in Escherichia coli. The left
column is the average over 400 randomly selected proteins and the right column is the average over all T3SS effectors. The left column has a similar
average for the real and scrambled sequences (P value.0.15). In the right columns, the real T3SS effectors sequences have a lower SIR score average
than randomly selected proteins (P-value=2.4e-3). Although E.coli effectors have a lower averaged SIR score than expected from their scrambled
sequences, the difference is not significant (P-value.0.3). Bordered bars represent results that are not consistent with the other MHC-I binding
algorithms, MLVO and NetMHC (figures 6 and 7, respectively).
doi:10.1371/journal.pcbi.1002220.g003
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among different E.Coli strains is very large. The typical EPEC differs
significantly at the genetic level from the atypical EPEC and EHEC. In
the typical EPEC strains (O127:H6, O103:H2, O111:H-), the SIR
score of effectors was not significantly lower than both their scrambled
sequences and non-effectors proteins (data not shown). These proteins
have very high epitope densities in two frequent alleles, A*0201 and
B*4001 (SIR scores of 1.8 and 3.5 compared with neutral SIR scores of
0.8 and 0.7, respectively). Since these alleles have high frequency
among the Caucasian population (accumulated frequency of 15%),
their donation to the averaged SIR score is very high. We have no clear
explanation for this observation. However, EHEC O157:H7, the most
important cause of severe diseases in the Western world [64] , and its
closely related atypical strain O55:H7, have the lowest SIR scores,
suggesting a strong selection pressure on specific strains. Given this high
heterogeneity, we cannot clearly prove selection in E.Coli in general.
T3SS-effectors epitopes have a much lower affinity than
other epitopes in bacteria
The absolute number of epitopes or their density might not give
the full picture regarding to escape mutations. Such mutations
could affect, for example, the quality of the epitopes. We have thus
checked if the epitopes still present on T3SS effectors have an
affinity similar to epitopes from other proteins. In order for
peptides to be presented on MHC-I molecules, they have to pass
three stages: Proteasomal cleavage, TAP translocation, and MHC-I
binding.
We computed the probability to pass these three stages using
proteasomal cleavage, TAP binding and MHC-I binding algo-
rithms. An epitope was defined as a peptide with a supra-threshold
score at each stage.
The averaged proteasomal cleavage, MHC-I binding and TAP
binding scores of epitopes derived from random bacterial proteins
and from effectors of the three gram-negative bacteria used in this
study are represented in Figure 4.
One can clearly see that most effectors have consistently lower
scores for cleavage, TAP binding and MHC binding. (T test 1.e-
10,P-value,0.06) with two exceptions: ExoU, that, consistent
with our previous results, has proteasomal cleavage score and
binding score higher than randomly selected proteins, and
proteasomal cleavage of E.coli where the differences are not
significant (T test P-value=0.388). Since these scores correspond
to the probability that a given peptide will be eventually presented
at MHC-I molecule, these results highlight again the efforts made
Figure 4. Average scores of epitope for all steps of epitope presentation (proteasomal cleavage, TAP binding and MHC-I binding)
in Shigella flexneri, Pseudomonas aeruginosa and Escherichia coli. The y axis values represent the score in each step. P. aeruginosa effector, ExoU,
being a unique necrosis effector was examined separately. In all bacteria tested, the average scores of epitopes in effectors in all stages are lower than
the scores of epitopes in randomly selected proteins (with one exception of proteasomal cleavage of E.coli). ExoU epitopes had higher proteasomal
cleavage and MHC-I binding scores in comparison to these scores of randomly selected proteins. Note that TAP is the less limiting factor in epitope
processing. All differences (except proteasomal cleavage of E.coli with P-value=0.388) are significant with 1.e-10,P-value,0.06.
doi:10.1371/journal.pcbi.1002220.g004
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cells: not only are there less epitopes in T3SS effectors, but the
remaining epitopes have lower probabilities of being presented.
Intracellular bacterial toxins are similar to Gram Negative
T3SS effectors in terms of immune-induced evolution
Cytosol localization of bacterial proteins is not unique to T3SS
effectors. While Intracellular bacteria are localized within host
cells, they usually do not reach the cytosol. Most of the bacteria
reside in the phagosome of the host cell. However, some bacterial
proteins are exposed to the host cytosol even in Intracellular
bacteria. Two examples for such bacteria are Listeria monocytogenes
and Mycobacterium tuberculosis.
Listeria monocytogenes
L. monocytogenes can escape from the phagosome and remain
in the cytosol. This escape occurs through the secretion of
pore forming toxin- listeriolysin O (LLO) [65] that degrades
the phagosomal membrane. LLO is a member of cholesterol-
dependent cytolysins (CDCs) – a large group of pore-forming
toxins that depends on membrane cholesterol for their activity.
This group consists of about 20 members (for a review see [66]),
each produced as a soluble monomeric protein that, in most cases,
is secreted by a type II secretion system. LLO is known to reside in
the cytosol. However, cytosolic LLO is much less active as a pore-
forming toxin. Instead, it is highly degraded due to a PEST-like
sequence that promotes its targeting to proteasomal cleavage,
preventing the pore forming in the cell membrane and the
sequential lysis of its host cell [67]. While in the cytosol,
L.monocytogenes secretes another protein, ActA that is used for actin
polymerization and horizontal movement within the intestinal
epithelial layer [68]. As expected from the results in the previous
sections, both LLO and ActA have a lower SIR score than 1
(T test P-value,7.6e-12) and both their scrambled versions
(ANOVA P-value=7.e-7), and randomly selected proteins (T test
P value,1.e-12 for LLO and ActA, separately, and ANOVA
P-value,1.e-12 for both proteins together). This suggests an
immune escape strategy of L. monocytogenes as in gram negative
bacteria. As in all previous cases, the average over randomly
selected proteins of L.monocytogenes does not show such a decrease in
the epitope density (Figure 5A).
Mycobacterium tuberculosis cytosolic proteins
Mycobacterium tuberculosis (TB) [61] resides in the phagosome of
lung macrophages. In MB, the ESAT-6 (esxA) and CFP10 (esxB)
proteins are secreted into the host cell and were proved to reach
the cytosol [22]. The access of these ESX-1 proteins to the cytosol
might be achieved either by the TB escape from the phagosome or
translocation of these proteins to the cytosol through sec61, or
alternatively directly by ESX-1. Consistent with these last two
options, these proteins were shown to induce CD8+ T-cell
response regardless of the escape of the bacteria from the cytosol
[22]. Besides these two proteins, there is a group of at least 18
ESAT-6 homologues. Very little is known about these proteins,
but they show homology to the ESAT-6 protein and are thus
suspected to be secreted by the same system [69].
Mycobacterium tuberculosis SIR scores
We tested both ESAT-6/CFP10 proteins and ESAT-6
homologues for their SIR score. Overall SIR scores of ESAT-6
family proteins are lower than 1 (T test p,1.e-15) and than their
scrambled versions (ANOVA P-value=3.5e-9) as well as in
comparison to randomly selected tuberculosis proteins (ANOVA
P-value,1.e-13). Moreover, when checking each protein sepa-
rately , ESAT-6, as well as 15 out of 18 of its homologues have
shown to have lower SIR scores than both randomly selected
proteins and their own scrambles sequences (T-test P-value,0.05).
CFP-10 and the ESAT-6 homologues esxC, esxE and esxU have
higher SIR scores than their neutral SIR scores (T-test P-
value,0.05) (Figure 5B). Two of the above proteins, esxE and
Figure 5. SIR score of cytosolic proteins and randomly selected proteins in Listeria monocytogenes and Mycobacterium tuberculosis. A)
Comparison between the average SIR score in real sequences and in scrambled sequences in Listeria monocytogenes. The cytosolic proteins
Listeriolysin O and ActA (second and third columns, respectively) have lower SIR scores than randomly selected proteins and than their scrambled
sequences (P-value,1.e-12 for both proteins). In randomly selected proteins (first column), the differences between real and scrambled sequences
was insignificant (P-value=0.8652). B) Comparison between the average SIR score in real sequences and in scrambled sequences in Mycobacterium
tuberculosis. The first two columns are the average SIR scores of EsxA and EsxB. Columns 3-20 are the scores of ESAT-6 homologues hypothetical
proteins. Column 21 is the averaged SIR score over all proteins in the Esx family, and the last column is the averaged scores of 400 randomly selected
proteins. In EsxA (ESAT-6), as well as in 15 out of 18 ESAT-6 homologues, the average SIR score in the real sequence is lower than the SIR score in
randomly selected proteins and their scrambled sequences. In randomly selected proteins, the differences between real and scrambled sequences
was insignificant (P-value=0.2212). These results argue that the hypothetical ESAT-6 homologues - like ESAT-6 itself – might be localized in the host
cytosol. *NS-not significant. All other differences are significant with P-value,0.05.
doi:10.1371/journal.pcbi.1002220.g005
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extracytoplasmic function subfamily of alternative sigma factors,
and were suggested to function in host modulation at later stages of
infection but seemed to have no importance in the pathogenesis of
acute infection [70]. One could assume that the consistent low SIR
score in most of this family members’ is due to sequence similarity.
We have calculated the edit distance between members of the
ESAT-6 family (divided by the length of the longer among the
compared proteins). As shown in Figure S2, most of ESAT-6
family members are very different from each other in their
sequences. This result suggests that the selection for immune
evasion has occurred in each protein separately. One can thus
summarize that CTL epitopes modulation is a mechanism
common to practically all cytosolic bacterial proteins.
The interesting case of ExoU – an indirect killer
In contrast with all other confirmed effectors, the SIR score of P.
aeruginosa’s ExoU was significantly higher than its neutral SIR score
(T test, p ,1e-9). Moreover, the candidate epitopes of ExoU have
a higher proteasomal cleavage and MHC-I binding scores than
other effectors or non-effector proteins (Figure 4). Thus not only is
ExoU not trying to hide, it seems it is making every possible effort
to expose itself. Taking into account that ExoU is secreted by
cytopathic strains of P. aeruginosa and is known to induce rapid cell
death in host-cells, we propose that these P. aeruginosa strains may
use the host immune system to induce cell death. Since the goal of
ExoU expression is to kill the cell, having the cell recognized by
CTLs may be the easiest way to obtain this goal. The utilization of
the host’s immune response by bacteria was suggested recently by
Gagneux et al [71]. In their study on TB, they detected hyper-
conserved epitopes in MTBC (Mycobacterium tuberculosis complex)
proteins, and suggested that the bacteria benefit from T-cell
recognition. Similarly, the extremely high epitope density found in
the ExoU protein suggests that over-presentation of this protein
acts to induce CD8+ T-cell response in the host-cell by the
cytopathic strains of P. aeruginosa as part of their mechanism to
induce cell death. We are now looking for similar effects in viruses.
Validation with other algorithms
In this study we have used the SIR formalism as used in our
previous studies. While this formalism was validated for some
alleles, its MHC-binding algorithm (BIMAS) is relatively old and
new algorithms have been introduced since then for some alleles.
In order to test that our results are not an artifact of the algorithms
used, we have tested the validity of our results using two other
algorithms: MLVO and NetMHC (see method section for
a detailed description of these algorithms).
When using the MLVO, the results were similar to the
traditional SIR score (based on BIMAS) results, and were often
more significant. For most bacteria tested, all effectors were shown
to have a lower SIR score than expected from their sequence. The
results were significant for most groups of proteins (Figure 6,
ANOVA p ,0.03). The exception were again the E.Coli that
showed a high variability among strains and proteins, and late
effectors of Shigella in which no significant differences were shown
(ANOVA P-value.0.5 for both E.coli and late Shigella effectors).
The main difference between the MLVO and BIMAS results was
that in the MLVO formalism, the SIR score of ExoU was lower
than its scrambled versions (T test P-value,0.04). Although the
accuracy of MLVO is better than most other algorithms for the
vast majority of alleles, this algorithm was not systematically tested
on other organisms. We thus use the MLVO results at this stage
only as a validation of the SIR results.
To further validate the results, we have repeated the analysis
using NetMHC. In most bacteria tested (again, with the exception
of E.Coli and late effectors of Shigella in which the differences was
not significant (ANOVA P-value.0.58 and 0.064, respectively)),
the SIR score predicted by the NetMHC of cytosolic proteins was
lower than their neutral SIR score (Figure 7, ANOVA P-value
,5.e-3). Consistent with MLVO but in contrast with BIMAS
formalism, ExoU score was lower than expected (T-test
P-value=0.012).
Taken together, in most cases our results using BIMAS
algorithm were in agreement with the results of MLVO and
NetMHC algorithms, and that the observed reduction in the
number of epitopes is not an artifact of a specific algorithm. A
summary of the significance of the results in all three algorithms
are presented in Supplementary Material (Table S3).
Figure 6. Validation of the results with MLVO algorithm. In
Pseudomonas, Shigella, Micobacterium and Listeria,t h ec y t o s o l i c
proteins have lower SIR scores than expected, consistent with our
previous results. However, the E.coli effectors had higher SIR scores than
expected from their sequence and ExoU have shown a lower SIR score
than expected, in contrast with the results using BIMAS. (P-value,0.08
for late Shigella proteins and P-value,0.04 for other proteins).
doi:10.1371/journal.pcbi.1002220.g006
Figure 7. Validation of the results with NetMHC algorithm. In
Pseudomonas, Shigella, Micobacterium and Listeria,t h ec y t o s o l i c
proteins have lower SIR scores than expected, consistent with our
previous results (P value,0.02). However, E.coli effectors showed no
significant differences between the real and neutral SIR scores and ExoU
have lower SIR score than expected (P value=0.012), in contrast with
the results using BIMAS.
doi:10.1371/journal.pcbi.1002220.g007
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We have performed a broad analysis of immune-induced
selection of CD8+ T-cells escape mutations in cytosolic bacterial
proteins. While in general CD8+ T-cell response induces very weak
selection, if at all, on bacterial proteins, a strong selection was
observed on the T3SS-effectors group of gram-negative bacteria
and probably on cytosolic bacterial proteins in general. Further-
more, the strength of the selection on the effectors depends on their
time of expression as can be seen in the case of S.flexneri where the
early set of effectors was selected more strongly than the late set.
These results are in good agreement with our previous studies on
herpesviruses [43], HIV [24] and viruses in general [25], showing
that proteins expressed in phases critical to the fate of infection (e.g.,
early lytic and latent) evaded immune detection more than others.
In order to validate these results, we have repeated the analysis
using a recently developed algorithm (the MLVO), as well as the
more classical NetMHC with similar results for the vast majority of
the proteins.
An intriguing possibility is that the direction of selection
depends on the function of the effectors. This was demonstrated
by the P. aeruginosa cell death mediated effector ExoU that has
evolved to have more epitopes, and thus, might induce CTL
response. The involvement of ExoU in inducing CTL response is
in good agreement with studies of corneal infection by the P.
aeruginosa strain which was shown to be dependent on ExoU
secretion [72]. Barrett et al. [73] have shown that mouse strains
favoring development of a Th1-type response are susceptible to
corneal infection, suggesting the involvement of CTL response in
this infection. Note that this result was not observed using MLVO,
and is thus left as a hypothesis to be checked further.
In E.Coli, a very high variability in the epitope density of
proteins and strains has been observed, as well as a large difference
between the epitope densities in different HLA alleles. We
currently have no clear explanation for this variability, except
perhaps for a specific adaption of EPEC and EHEC to different
populations and thus different epitope densities distributions
among HLA alleles. Thus, in contrast with all other bacteria
tested here, we cannot safely claim that E.Coli effectors proteins
have evolved to avoid detection. Further research is needed to
understand the peculiar differences between E.Coli strains.
Compared with viruses, bacteria have a relatively low mutation
rate of approximately 1.e-8 (as compared with approximately 1.e-5
in viruses). Considering the lack of species specificity and the
horizontaltransfer ofmanygenes,includingthe membersoftype III
secretion system, bacteria are much less genetically flexible, and
therefore, epitope density within a protein might be influenced not
onlyby the immune-induced selection butalsobythe time when the
horizontal transfer took place and the variety of species infected by
the bacteria, forcing them to adapt to different HLA alleles and
other species-specific constraints. A way to maximize the evolu-
tionaryconservation of epitopes (orthelackof epitopes)is to directly
affect the cleavage mechanism that is common to most mammals.
Indeed, when computing the proteasomal cleavage ratio (number of
nine-mersthataretheresultsofproteasomalcleavage divided bythe
total number of nine-mers), effector proteins had a lower ratio than
other proteins in all bacteria. These results were significant for P.
aeruginosa effectors and late and early S. flexneri effectors (T-test, P-
values=5.7e-5, 4.3e-5 and 6.6e-45, respectively), and insignificant
for E. coli effectors (p=0.1) (Figure 8).
The current analysis shows that an important part of the
immune response against bacteria may be the CTL response
against cytosolic bacterial proteins. This response may be a key
element in the development of future anti-bacterial therapies.
Methods
Bacterial sequences
Pseudomonas aeruginosa, Escherichia coli, Shigella flexneri, Listeria
monocytogenes and Mycobacterium tuberculosis gene sequences were
used for this analysis. The sequences were obtained from the
NCBI (http://www.ncbi.nlm.nih.gov/) database. All sequences
are available in the Supplementary Material. For P. aeruginosa,w e
used 16 ExoU sequences and 18 sequences of the 3 other effectors.
For S. flexneri, we used 75 early effectors and 30 late effectors
sequences. For E. coli, we used 38 effectors sequences (11 Tir, 4
EspF, 4 EspH, 14 EspZ and 5 Map). For L. monocytogenes, we used
107 listeriolysin sequences and 483 ActA sequences. For M.
tuberculosis, we used 62 Esat-6 proteins sequences. For all bacteria,
we took 400 sequences of random non-effectors proteins. For each
protein sequence, we produced 50 scrambled sequences as
a reference.
SIR score
We have analyzed the ratio between the number of epitopes
presented in bacterial proteins and their random counterpart. This
ratio was defined as the Size of Immune Repertoire (SIR) score.
The epitope number was computed using three algorithms:
a proteasomal cleavage algorithm [39], a TAP binding algorithms
developed by Peters et al. [40] and the BIMAS MHC binding [74]
algorithms. We have computed epitopes for the 33 most common
HLA alleles and weighted the results according to the allele
frequency in the global human population (Figure 1). The
algorithms’ quality was systematically validated vs. epitope
databases and was found to induce low FP and FN error rates.
The computation of the SIR scores can be performed through our
web-server at http://peptibase.cs.biu.ac.il/index.html.
The comparison between effectors and their scrambled
sequences, as presented in Figures 3–8, was done on the average
of the entire group of proteins. We have also tested the possibility
of first averaging each protein separately and then to average the
results over all proteins, as we have previously done for some viral
proteins [25,43,44,75]. There is no major difference between the
results in the two approaches. The results using the latter approach
are represented in the Supplementary Material (Figure S1).
Figure 8. Fraction of peptides derived from proteasomal
cleavage in Escherichia coli, Pseudomonas aeruginosa and Shigella
flexneri. T3SS effectors have less possible cleavage- derived nine-mers
than other proteins. Moreover, in S. flexneri, among effectors, early
secreted effectors have less cleavage-derived nine-mers than the late
secreted ones. *P-value,1e-4 for P.aeruginosa and late effectors of S.
flexneri, and P-value,1e-44 for early effectors of S. flexneri.I nE.coli, the
differences in fraction of cleavage derived peptides between effectors
and other proteins was not significant (P-value=0.1).
doi:10.1371/journal.pcbi.1002220.g008
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Given a peptide with N- and C-terminal flanking regions FN
and FC and residues P1, .Pi,..Pn, where Pi represents any residue






A peptide with a high score, S, has a high probability of being
produced, while a low score corresponds to a low probability of
production. The appropriate values for S1 to S5 were learned
using a simulated annealing process [76]. The algorithm was
validated to give a rate of false positives of less than 16% and a rate
of false negatives of less than 10% [39].
TAP binding frequency
The probability that a peptide binds the transporter associated
with antigen processing (TAP) machinery is mainly a function of
the residues at the first three N-terminal and the last C-terminal
positions. Moreover, this probability can be estimated through
a linear combination of the binding energies of the residues.
Multiple algorithms for TAP binding frequency were checked.
The score computed by Peters et al. [77] gave the best
differentiation between presented and random peptides [46].
MHC binding motifs
Each protein was divided into all possible nine-mers by using
a sliding window (e.g., a 300-amino-acid protein was divided into
292 nine-mers, positions 1 to 9, positions 2 to 10, and so on). For
each nine-mer, we computed the MHC binding energies of 31
different class I human leukocyte antigen (HLA) molecules, most
of them HLA-A and HLA-B. The affinity of a candidate peptide
for each HLA molecule was estimated using the BIMAS software
and the binding coefficients predicted by Parker ([78]; http://
www-bimas.cit.nih.gov/molbio/hla_bind/).
These matrices estimate the contribution of each amino acid at
each position to the total binding strength. While many more
modern algorithms exist for MHC binding prediction, we have
previously found the BIMAS algorithm to provide trustworthy
results in most highly frequents alleles that compose the bulk of the
score analyzed here [24,33,43].
Multi-Label Vector Optimization (MLVO)
The MLVO algorithm [79] for MHC and TAP binding
prediction finds a classifier (w) using three label types that are
combined into a single constrained optimization problem. The
method finds the optimal combination of binary classification of
peptides known to bind or not to bind the MHC/TAP molecule,
a linear regression based on the measured affinities of peptides with
a known IC50 or EC50 binding concentrations and a guess (often
based on information on similar alleles). In the current analysis, we
have used the MLVO algorithm for MHC binding [79], as well as
for TAP binding. The MHC binding accuracy of the vast majority
of MHC-I alleles inthe MLVO is over 0.95(with AUCof over 0.98)
[79]. As in all other cases, the SIR results presented are a weighted
average over alleles of the ratio between the computed epitope
density and the one expected in a random sequence.
NetMHC
The NetMHC algorithm uses an artificial neural network
(ANN) based method for MHC binding prediction [80]. The ANN
is trained by eluted MHC ligands for which binding affinity data is
measured. We define an epitope as a peptide that exceeds the
threshold of 500 nM (’weak binder’), and calculated the SIR score
accordingly. In order to compare the NetMHC results to the
BIMAS and MLVO results, we applied the Ginodi cleavage
algorithm [39] and the Peters TAP binding score [40] . Only
peptides having a supra-threshold score were tested for MHC
binding. Again, the SIR results presented are a weighted average
over alleles of the ration between the computed epitope density
and the one expected in a random sequence.
Thresholds
The different epitope prediction algorithms provide a binding
score. In order to produce an epitope list, a cutoff should be
applied to these scores. There are two possibilities to use thresholds
for the definition of epitopes: a single affinity threshold for all
alleles, or an allele dependent threshold. The first attitude is based
on the need to bind the MHC molecule for a long enough period
to activate T cells. The second attitude is based on the competition
for the presentation on a limited number of MHC molecules. For
example, an allele such as B*2705 is expected to present a very
large number of epitopes from self proteins [81]. Thus a viral
protein with a large number of epitopes would have to compete
with a similarly high number of epitopes in human proteins. We
here use the second option where we have computed an allele
specific presentation threshold value that limits the number of
predicted presented epitopes from a random sequence (Supple-
mentary Material, Table S1). While this may lead to the exclusion
of some real viral epitopes, it should not affect the ratio between
the number of computed epitopes in real and scrambled
sequences. Cutoffs for all alleles can be found in the Supplemen-
tary Material (Table S1).
Statistical analysis
The SIR score of various populations was compared to the
expected score. A two way nested ANOVA was used to compare
the SIR scores of bacterial proteins in real vs. scrambled sequences,
as well as the SIR score of effector vs. other proteins in bacteria.
The ANOVA analysis was performed using two layers of variables:
the main group -effector/non-effector or real/scrambled and the
second, nested within the first is the protein identity.
A two way T-test with unknown and unequal variance was used
in cases where no layers has to be considered (comparison SIR
score of each protein groups to 1, and comparison of the averaged
proteasomal cleavage, tap binding and MHC-I binding scores of
epitopes in effectors and non-effector proteins).
Epitope computation
We have designed a CD8+ T cell epitope SQL based library
webserver: http://peptibase.cs.biu.ac.il. This website provides
detailed CD8+ T cell epitope libraries for the human and mouse
genomes as well as for most fully sequenced viruses. It also allows
users to upload a file and produce an epitope library. All bacterial
proteins in this study were analyzed for their epitope using this
webserver.
Supporting Information
Figure S1 SIR score of effector groups, averaged each protein by
itself.
(TIF)
Figure S2 Similarity among ESAT-6 like family proteins.
Similarities are represented by the edit distance divided by the
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compared.
(TIF)
Table S1 MHC-I allleles used in the analysis. The first column
describes the allele frequency in Caucasian population (http://
www.ebi.ac.uk/imgt/hla/). The second column describes the
presentage of random epitopes that bind to the allele, and the
third column describes the cutoff used by the algorithm to classify
binders/non-binders.
(TIF)
Table S2 SIR score and neutral SIR score for each protein in the
study.
(TIF)
Table S3 Comparison between the results of BIMAS,
MLVO and NetMHC algorithms and their significance.
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